Veterinary Medicines

Fungiconazol 400 mg tablets for dogs

Authorised
  • Ketoconazole
Download as PDF

Product identification

Medicine name:
FUNGICONAZOL 400 MG TABLETS FOR DOGS
Fungiconazol 400 mg tablets for dogs
Active substance:
  • Ketoconazole
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ketoconazole
    400.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ02AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Cardboard box of 1 Aluminium/PVC/PE/PVDC blister containing 10 tablets each.
  • Cardboard box of 10 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 9 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 8 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 7 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 6 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 5 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 4 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 3 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.
  • Cardboard box of 2 Aluminium/PVC/PE/PVDC blisters containing 10 tablets each.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
  • Lelypharma B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22622/047/002
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0263/002
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."